Literature DB >> 6539301

Effect of pertussigen on inflammation caused by Freund adjuvant.

J J Munoz, W A Sewell.   

Abstract

Pertussigen, one of the toxins from Bordetella pertussis, greatly increased the inflammatory response produced by complete Freund adjuvant in the footpads of mice. This effect was not produced by pertussigen when the emulsion was made with saline and incomplete Freund adjuvant, but if an antigen was included in incomplete Freund adjuvant, the strong potentiating effect was again demonstrated. As little as 100 ng of pertussigen given intravenously was effective, but 400 ng proved better, and this latter dose was used routinely. The most striking action occurred when pertussigen was injected on the same day or 3 days after complete Freund adjuvant, but an effect was demonstrated when given from 3 days before to 6 days after complete Freund adjuvant. The action of pertussigen was not apparent until about 6 to 8 days after complete Freund adjuvant. The footpad swelling reached its maximum by day 14 and remained undiminished until day 29. Forty days later, a significant effect was still present. Histologically, the cellular infiltrate in the feet of mice injected with complete Freund adjuvant was more intense in animal treated with pertussigen. Nude BALB/c mice receiving an emulsion of complete Freund adjuvant in the footpads did not respond with an increased inflammation after receiving pertussigen, suggesting the possible involvement of T cells in this phenomenon. The intense and prolonged inflammatory response produced in pertussigen-treated mice by Freund adjuvant containing antigenic substances may serve as a useful model to study chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539301      PMCID: PMC263653          DOI: 10.1128/iai.44.3.637-641.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A HYPERACUTE FORM OF ALLERGIC ENCEPHALOMYELITIS.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

Review 2.  Role of basophils, mast cells, and vasoamines in hypersensitivity reactions with a delayed time course.

Authors:  P W Askenase
Journal:  Prog Allergy       Date:  1977

Review 3.  Biological activities of immunoglobulins of different classes and subclasses.

Authors:  H L Spiegelberg
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

4.  Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. I. Suppression of cellular hypersensitivity reactions.

Authors:  T Ochiai; K Okumura; T Tada; S Iwasa
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

5.  The mode of action of mineral-oil emulsion adjuvants on antibody production in mice.

Authors:  W J Herbert
Journal:  Immunology       Date:  1968-03       Impact factor: 7.397

6.  Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen.

Authors:  T J Athanassiades
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

7.  Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins.

Authors:  C C Bernard; P R Carnegie
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

8.  Biological activities of crystalline pertussigen from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R K Bergman; P L Sadowski
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

9.  Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions.

Authors:  R K Gershon; P W Askenase; M D Gershon
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

10.  Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis.

Authors:  R N Taub; W Rosett; A Adler; S I Morse
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  2 in total

1.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Is inflammation a consequence of extracellular hyperosmolarity?

Authors:  Laurent Schwartz; Adeline Guais; Mohammad Pooya; Mohammad Abolhassani
Journal:  J Inflamm (Lond)       Date:  2009-06-23       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.